ResMed showed 29% EPS growth last quarter. Sales gains came in at 10%. ResMed earns the No. 6 rank among its peers in the ...

Shares of ResMed Inc. RMD rallied 1.80% to $236.63 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 and Dow ...

StockNews.com cut shares of ResMed (NYSE:RMD – Free Report) from a buy rating to a hold rating in a research note published on Friday morning. Several other equities analysts have also issued reports ...

Buying $1000 In RMD: If an investor had bought $1000 of RMD stock 10 years ago, it would be worth $3,648.09 today based on a ...

Stifel lowered the firm’s price target on ResMed (RMD) to $240 from $250 and keeps a Hold rating on the shares. After having gathered survey ...

Shares of ResMed Inc. (NYSE:RMD – Get Free Report) have earned a consensus rating of “Moderate Buy” from the fifteen research ...

Citi upgraded ResMed (RMD) to Buy from Neutral with a price target of A$44, up from A$41. The firm likes the stock’s “reasonable valuation, ...

ResMed Inc.’s RMD growth in the second quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its Device sales continue to drive overall revenue growth. The company’s ...

A new survey finds that 33% of Singaporeans suffer from poor sleep—affecting productivity, relationships, and well-being.

Shares of ResMed Inc. RMD advanced 3.29% to $232.44 Friday, on what proved to be an all-around positive trading session for ...